Non-Small Cell Lung Cancer Market

Future Market Insights

Key Insight

The non-small cell lung cancer market is projected to grow from USD 11.5 billion in 2025 to USD 23.0 billion by 2035, at a CAGR of 7.2%. Adenocarcinoma will dominate with a 45.5% market share, while chemotherapy will lead the treatment segment with a 38.0% share.

August 04, 2025

Anurag Sharma

285 Pages

Cite this Report

Non-Small Cell Lung Cancer Market

https://www.futuremarketinsights.com/reports/non-small-cell-lung-cancer-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Astellas Pharma Inc
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb
Novartis
The Vanguard Group

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Non-Small Cell Lung Cancer Market

Key Players

Similar Industry Reports